Our cells hold about two meters of DNA, folded and compacted to fit inside a nucleus far narrower than a strand of human hair. That packing is essential for life, but it creates a problem for scientists. Some of the…
UNIVERSITY PARK, Pa. — Xiaojun “Lance” Lian, associate professor of biomedical engineering and of biology at Penn State, alongside biomedical engineering doctoral candidate Tahir Haideri contributed to a paper recently published in Matter. The research, led by scientists at the University…
Bioengineer.org
The more mechanistically novel of Thursday's two programs is Evommune's. The company, which had staked its near-term story on EVO756 — an oral drug targeting a G-protein-coupled receptor — saw that bet dissolve over the spring and summer. EVO756 failed to meet its primary endpoint…
Reposted from the College of Engineering. A new grant from the National Institutes of Health will accelerate University of Utah research using biomedical chip technology to better understand keratoconus, a potentially blinding disease that causes the eye's cornea to thin…
BioPharm International FAQ: What FDA’s Individualized Gene Editing Draft Guidance Means for Developers FDA’s draft framework would let sponsors add patient-specific genome editing variants to an approved BLA using in vitro data. Here is what the guidance proposes, what evidence…
GenomeWeb Precision BioSciences Aiming to Raise $125M for Gene Therapies
Brian Salmons, Austrianova's CEO added "This publication provides the background and future perspectives for our ongoing collaboration with Avaí Bio through Austrianova announces the publication of a peer-reviewed article on the use of implanted Cell-in-a-Box encapsulated cells for the sustained…
That reasoning proved correct. Loop-inducing guides retain effective target binding in cells while inhibiting the downregulation that generally results from AGO2 association, a finding that matters because it decouples the targeting function of AGO2 from its usual silencing function. This sets the…
Researchers report the first successful genetic transformation of the biomaterial-producing fungus Fomes fomentarius, including working fluorescent protein markers and an unexpected DNase obstacle. News Source: Roger Howard. (November 6, 2026). Scientists crack open the tinder fungus with first genetic transformation toolkit. Scienmag.
CRISPR edits, delivery vectors, rare‑disease trials, and approvals.
An article joins this feed when it matches these terms. Each one is also a search of its own.